Biomerica (BMRA) Depreciation & Amortization (CF) (2010 - 2026)
Biomerica (BMRA) reported Depreciation & Amortization (CF) of $20000.0 for Q1 2026, down 4.76% on a YoY basis from $21000.0 in Q1 2025, and little changed sequentially from $20000.0 in Q4 2025.
Biomerica (BMRA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $20000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 4.76% year-over-year to $20000.0; the trailing twelve-month figure through Feb 2026 stood at $83000.0 (down 3.49% YoY), and the FY2025 full-year result was $87000.0, up 7.41% from the prior year.
- Depreciation & Amortization (CF) held at $20000.0 in Q1 2026, from $20000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $236728.0 in Q2 2022 to a low of $18000.0 in Q1 2023.
- A 5-year average of $34254.8 and a median of $21000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) soared 441.5% in 2022 and slumped 92.4% in 2023, its largest moves.
- Tracing BMRA's Depreciation & Amortization (CF) over 5 years: stood at $19000.0 in 2022, then declined by 5.26% to $18000.0 in 2023, then rose by 22.22% to $22000.0 in 2024, then retreated by 9.09% to $20000.0 in 2025, then changed by 0.0% to $20000.0 in 2026.
- Business Quant data shows BMRA's Depreciation & Amortization (CF) at $20000.0 in Q1 2026, $20000.0 in Q4 2025, and $20000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 20,000.00 |
| Feb 28, 2026 | 20,000.00 |
| Nov 30, 2025 | 20,000.00 |
| Nov 30, 2025 | 20,000.00 |
| Aug 31, 2025 | 20,000.00 |
| Aug 31, 2025 | 20,000.00 |
| May 31, 2025 | 23,000.00 |
| May 31, 2025 | 23,000.00 |
| Feb 28, 2025 | 21,000.00 |
| Feb 28, 2025 | 21,000.00 |
| Nov 30, 2024 | 22,000.00 |
| Nov 30, 2024 | 22,000.00 |
| Aug 31, 2024 | 21,000.00 |
| Aug 31, 2024 | 21,000.00 |
| May 31, 2024 | 22,000.00 |
| May 31, 2024 | 22,000.00 |
| Feb 29, 2024 | 20,000.00 |
| Feb 29, 2024 | 20,000.00 |
| Nov 30, 2023 | 18,000.00 |
| Nov 30, 2023 | 18,000.00 |